REFERENCES
- Boulard, Y, Landau, I., Miltgen, F., Ellis, D. S. & Peters, W. (1983). The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis Part III: Ultrastructural changes induced in exoerythrocytic schizonts of Plasmodium yoelii yoelii by primaquine. Annals of Tropical Medicine and Parasitology, 77, 555–568.
- Davidson, D. E. Jr., Ager, A. L., Brown, J. L., Chapple, F. E., Whitmire, R. E. & Rossan. R. N. (1981). New tissue schizontocidal antimalarial drugs. Bulletin of the World Health Organization, 59, 463–479.
- Peters, W., Davies, E. E. & Robinson, B. L. (1975). The chemotherapy of rodent malaria, XXIII. Causal prophylaxis, Part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening. Annals of Tropical Medicine and Parasitology, 69, 311–328.
- Peters, W., Howells, R. E., Portus, J. H., Robinson, B. L., Thomas, S. C. & Warhurst, D. C. (1977). The chemotherapy of rodent malaria. XXVII. Studies on mefloquine (WR 142, 490). Annals of Tropical Medicine and Parasitology, 71, 407–418.
- Seureau, C., Szollosi, A., Boulard, Y., Landau, I. & Peters, W. (1980). Aspects ultrastructureaux de la rélation hôte-parasite entre le schizonte de Plasmodium yoelii et la cellule hépatique du rat. Protistologica, 16, 419–426.
- WHO(1983). Development of mefloquine as an antimalarial drug. Bulletin of the World Health Organization, 61, 169–178.